Andrographolide AD

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAndrographolide AD
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionConnective tissue growth factor inhibitorsNuclear factor NF-kappa-B complex inhibitorsNitric oxide inhibitors +[8] 
TargetsNuclear factor NF-kappa-B complexGlycogen synthase kinase-3 betaProtein kinase C +[5] 
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInnobioscience Llc
China Registration ClassN/A

Develop Information

Active CompaniesInnobioscience Llc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A